Wilhelm M - Search Results

1

KOKON: A Germany-Wide Collaborative Research Project to Identify Needs, Provide Information, Foster Communication and Support Decision-Making about Complementary and Alternative Medicine in Oncology.

Güthlin C, Bartsch HH, Joos S, Längler A, Lampert C, Ritter C, Schildmann J, Weis J, Wilhelm M, Witt CM, Horneber M. Güthlin C, et al. Among authors: wilhelm m. Complement Med Res. 2020;27(2):105-111. doi: 10.1159/000502945. Epub 2019 Nov 13. Complement Med Res. 2020. PMID: 31722354 Free article. Review. English.

2

[Model projects in integrated oncology].

Dobos G, Wilhelm M. Dobos G, et al. Among authors: wilhelm m. Onkologie. 2012;35 Suppl 5:21-5. doi: 10.1159/000340027. Epub 2012 Aug 10. Onkologie. 2012. PMID: 22965290 German. No abstract available.

3

[Proposals for the advancement of certification].

Wilhelm M. Wilhelm M. Onkologie. 2012;35 Suppl 4:18-20. doi: 10.1159/000337997. Epub 2012 May 11. Onkologie. 2012. PMID: 22678071 Free article. German. No abstract available.

4

[Durvalumab after chemoradiotherapy is currently the most promising treatment for stage III NSCLC].

Wilhelm M. Wilhelm M. Strahlenther Onkol. 2019 Jul;195(7):691-692. doi: 10.1007/s00066-019-01456-3. Strahlenther Onkol. 2019. PMID: 30949719 German. No abstract available.

5

[Relationship between prior antibiotic treatment and response to immune checkpoint inhibitor therapy and survival in patients with cancer].

Bauereiß A, Wilhelm M. Bauereiß A, et al. Among authors: wilhelm m. Strahlenther Onkol. 2020 May;196(5):486-487. doi: 10.1007/s00066-020-01601-3. Strahlenther Onkol. 2020. PMID: 32166450 German. No abstract available.

6

[(Mis) management in healthcare].

Overkamp F, Thiele KP, Wilhelm M. Overkamp F, et al. Among authors: wilhelm m. Onkologie. 2013;36 Suppl 5:20-7. doi: 10.1159/000352001. Epub 2013 Jul 1. Onkologie. 2013. PMID: 23921802 Free article. German. No abstract available.

7

[Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab].

Wilhelm M. Wilhelm M. Strahlenther Onkol. 2017 Mar;193(3):234-235. doi: 10.1007/s00066-017-1098-9. Strahlenther Onkol. 2017. PMID: 28120006 German. No abstract available.

8

[Impaired cognitive function and structural changes in cerebral white matter after chemotherapy].

Wilhelm M. Wilhelm M. Strahlenther Onkol. 2012 Jun;188(6):525-6. doi: 10.1007/s00066-012-0111-6. Strahlenther Onkol. 2012. PMID: 22552815 German. No abstract available.

9

[Risk of venous thromboembolism in patients with cancer treated with cisplatin: A systematic review and meta-analysis].

Wilhelm M. Wilhelm M. Strahlenther Onkol. 2013 Aug;189(8):704-5. doi: 10.1007/s00066-013-0386-2. Strahlenther Onkol. 2013. PMID: 23793866 German. No abstract available.

10

[No addition benefit from coadministration of trastuzumab and anthracyclines].

Wilhelm M. Wilhelm M. Strahlenther Onkol. 2014 Apr;190(4):428-9. doi: 10.1007/s00066-014-0558-8. Strahlenther Onkol. 2014. PMID: 24638245 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,453 results

Search Page

Filters